These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31170316)

  • 1. Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder.
    Pedrotti Moreira F; Cardoso TC; Mondin TC; Wiener CD; de Mattos Souza LD; Oses JP; Jansen K; da Silva RA
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):590-593. PubMed ID: 31170316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors, clinical features and gender differences in depression.
    de Azevedo Cardoso T; Mondin TC; Wiener CD; Marques MB; Fucolo Bde Á; Pinheiro RT; de Souza LD; da Silva RA; Jansen K; Oses JP
    Neurochem Res; 2014 Aug; 39(8):1571-8. PubMed ID: 24899094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the association between depression, suicidality and serum neurotrophin levels in adolescents.
    Bilgiç A; Çelikkol Sadıç Ç; Kılınç İ; Akça ÖF
    Int J Psychiatry Clin Pract; 2020 Jun; 24(2):143-150. PubMed ID: 32027188
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk.
    Wiener CD; de Mello Ferreira S; Pedrotti Moreira F; Bittencourt G; de Oliveira JF; Lopez Molina M; Jansen K; de Mattos Souza LD; Rizzato Lara D; Portela LV; da Silva RA; Oses JP
    J Affect Disord; 2015 Sep; 184():245-8. PubMed ID: 26118751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder.
    da Silva SK; Wiener C; Ghisleni G; Oses JP; Jansen K; Molina ML; Silva R; Souza LD
    Braz J Psychiatry; 2018; 40(4):361-366. PubMed ID: 29898192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.
    Xiong P; Zeng Y; Wu Q; Han Huang DX; Zainal H; Xu X; Wan J; Xu F; Lu J
    J Clin Psychiatry; 2014 Aug; 75(8):e794-801. PubMed ID: 25191916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
    Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder.
    Schröter K; Brum M; Brunkhorst-Kanaan N; Tole F; Ziegler C; Domschke K; Reif A; Kittel-Schneider S
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):169-181. PubMed ID: 30929061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
    Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML
    J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder.
    Inal-Emiroglu FN; Karabay N; Resmi H; Guleryuz H; Baykara B; Alsen S; Senturk-Pilan B; Akay A; Kose S
    J Affect Disord; 2015 Aug; 182():50-6. PubMed ID: 25973783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.
    Lhullier AC; Moreira FP; da Silva RA; Marques MB; Bittencourt G; Pinheiro RT; Souza LD; Portela LV; Lara DR; Jansen K; Wiener CD; Oses JP
    Alcohol Clin Exp Res; 2015 Jan; 39(1):30-3. PubMed ID: 25623403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features.
    Patas K; Penninx BW; Bus BA; Vogelzangs N; Molendijk ML; Elzinga BM; Bosker FJ; Oude Voshaar RC
    Brain Behav Immun; 2014 Feb; 36():71-9. PubMed ID: 24140302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief psychoeducation for bipolar disorder: Evaluation of trophic factors serum levels in young adults.
    Wiener CD; Molina ML; Moreira FP; Dos Passos MB; Jansen K; da Silva RA; de Mattos Souza LD; Oses JP
    Psychiatry Res; 2017 Nov; 257():367-371. PubMed ID: 28803094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder.
    Zhang X; Ru B; Sha W; Xin W; Zhou H; Zhang Y
    Asia Pac Psychiatry; 2014 Sep; 6(3):302-7. PubMed ID: 24436216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Brain-Derived Neurotrophic Factor Correlates Negatively with Severity and Duration of Major Depressive Episodes.
    Kheirouri S; Noorazar SG; Alizadeh M; Dana-Alamdari L
    Cogn Behav Neurol; 2016 Mar; 29(1):24-31. PubMed ID: 27008247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
    J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity.
    Sun J; Kong L; Wu F; Wei Y; Zhu Y; Yin Z; Deng X; Jiang X; Tang Y; Wang F
    J Affect Disord; 2019 Feb; 245():602-607. PubMed ID: 30445385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.